Related Experiment Videos
Hemophiliac patients in surgery. Implications for perioperative nurses
D Kleinert1, M Cahill-Bordas, M W Hilgartner
1New York Hospital-Cornell University Medical Center.
AORN Journal
|October 1, 1990
Abstract:
The introduction of plasma clotting factor concentrates has changed the treatment of patients with clotting factor deficiencies dramatically. They have enabled hemophiliacs to be independent and have some control over the management of their disease as informed participants. This has played a role in shortening the number of hospitalizations that hemophiliacs may have to endure and to decrease the length of stay when they are admitted. Additionally, staff who care for these patients do not need to be afraid of the disease if they are aware of the disease process and the therapy available for its amelioration.